Outcomes of Patients Treated for Hepatoblastoma with Low Alpha-Fetoprotein and/or Small Cell Undifferentiated Histology: A Report from the Children's Hepatic Tumors International Collaboration (CHIC).

AFP Hepatoblastoma SCU (small cell undifferentiated) SMARCB1 rhabdoid

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
11 Jan 2023
Historique:
received: 08 12 2022
revised: 24 12 2022
accepted: 25 12 2022
entrez: 21 1 2023
pubmed: 22 1 2023
medline: 22 1 2023
Statut: epublish

Résumé

Small cell undifferentiated (SCU) histology and alpha-fetoprotein (AFP) levels below 100 ng/mL have been reported as poor prognostic factors in hepatoblastoma (HB); subsequent studies reported

Identifiants

pubmed: 36672416
pii: cancers15020467
doi: 10.3390/cancers15020467
pmc: PMC9857147
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : European Network for Cancer Research in Children and Adolescents
ID : 261474
Organisme : Hepatoblastoma Foundation
ID : none
Organisme : Japan Agency for Medical Research and Development (AMED)
ID : 17ck0106332h0001
Organisme : Japan Society for the Promotion of Science (JSPS KAKENHI)
ID : JP16H02778
Organisme : Swiss Cancer Research
ID : KFS- 3936-08-2016

Références

J Pediatr Surg. 2002 Oct;37(10):1488-90
pubmed: 12378463
Pediatr Blood Cancer. 2020 Aug;67(8):e28350
pubmed: 32383794
Cancer. 2001 Dec 15;92(12):3130-4
pubmed: 11753992
J Immunol Methods. 1992 Jul 6;151(1-2):47-66
pubmed: 1378475
Lancet Oncol. 2017 Jan;18(1):122-131
pubmed: 27884679
J Clin Oncol. 2010 May 20;28(15):2584-90
pubmed: 20406943
Pediatr Radiol. 2009 Aug;39(8):817-22
pubmed: 19452146
J Clin Oncol. 2022 Feb 10;40(5):459-467
pubmed: 34874751
Pediatr Blood Cancer. 2009 Mar;52(3):328-34
pubmed: 18985717
J Pediatr Surg. 2002 Jun;37(6):851-6
pubmed: 12037748
Cancer. 1989 Sep 1;64(5):1082-95
pubmed: 2547506
Genes Chromosomes Cancer. 2016 Dec;55(12):925-931
pubmed: 27356182
Eur J Cancer. 1997 Jul;33(8):1243-9
pubmed: 9301450
Eur J Cancer. 2008 Mar;44(4):545-50
pubmed: 18166449
J Clin Oncol. 2000 Jul;18(14):2665-75
pubmed: 10894865
Clin Biochem Rev. 2004 May;25(2):105-20
pubmed: 18458713
Pathology. 2008 Dec;40(7):664-70
pubmed: 18985520
Pediatr Surg Int. 2011 Jan;27(1):1-8
pubmed: 20922397
Am J Surg Pathol. 1996 Nov;20(11):1394-400
pubmed: 8898844
J Pediatr Hematol Oncol. 2007 Jun;29(6):406-8
pubmed: 17551403
Cancer. 2009 Dec 15;115(24):5828-35
pubmed: 19813275
Pediatr Hematol Oncol. 1998 Mar-Apr;15(2):135-42
pubmed: 9592840
Hum Pathol. 2015 Apr;46(4):620-4
pubmed: 25649007
Klin Padiatr. 2019 Nov;231(6):283-290
pubmed: 31645068
Eur J Cancer. 2016 Jan;52:92-101
pubmed: 26655560
Curr Opin Pediatr. 2014 Feb;26(1):19-28
pubmed: 24322718
Ann Clin Biochem. 2006 Jul;43(Pt 4):314-7
pubmed: 16824284
Mod Pathol. 2014 Mar;27(3):472-91
pubmed: 24008558
Pediatr Blood Cancer. 2011 Sep;57(3):423-8
pubmed: 21744471

Auteurs

Angela D Trobaugh-Lotrario (AD)

Department of Pediatric Hematology/Oncology, Providence Sacred Heart Children's Hospital, Spokane, WA 99204, USA.

Rudolf Maibach (R)

IBCSG Coordinating Center, 3008 Bern, Switzerland.

Daniel C Aronson (DC)

Department of Pediatric Surgery, University Children's Hospital Zurich, 8032 Zurich, Switzerland.

Arun Rangaswami (A)

Division of Pediatric Hematology and Oncology, University of California, San Francisco, CA 94143, USA.

Beate Häberle (B)

Division of Pediatric Surgery, Dr. von Hauner Children's Hospital, Ludwig-Maximilians-University Munich, 80337 Munich, Germany.

Allison F O'Neill (AF)

Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston Children's Hospital and Harvard Medical School, Boston, MA 02215, USA.

Irene Schmid (I)

Department of Pediatric Hematology and Oncology, Dr. von Hauner Children's Hospital, Ludwig-Maximilians-University Munich, 80337 Munich, Germany.

Marc Ansari (M)

Pediatric Department, Onco-Hematology Unit, University of Geneva Hospitals, 1211 Geneva, Switzerland.

Tomoro Hishiki (T)

Department of Pediatric Surgery, Chiba University Graduate School of Medicine, Chiba 260-8677, Japan.

Sarangarajan Ranganathan (S)

Division of Pathology and Laboratory Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.

Rita Alaggio (R)

Department of Pathology, Bambino Gesu Children's Hospital, 00165 Rome, Italy.

Ronald R de Krijger (RR)

Department of Pathology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands.
Laboratory for Childhood Cancer Pathology, Princess Maxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, The Netherlands.

Yukichi Tanaka (Y)

Department of Pathology, Kanagawa Children's Medical Center, Yokohama 232-0066, Japan.

Soo-Jin Cho (SJ)

Department of Pathology, University of California, San Francisco, CA 94143, USA.

Christian Vokuhl (C)

Institute of Pathology, University Hospital Bonn, 53127 Bonn, Germany.

Rebecca Maxwell (R)

Division of Pediatric Surgery, Dr. von Hauner Children's Hospital, Ludwig-Maximilians-University Munich, 80337 Munich, Germany.

Mark Krailo (M)

Department of Population and Public Health Sciences, University of Southern California, Los Angeles, CA 90032, USA.

Eiso Hiyama (E)

Department of Pediatric Surgery, Hiroshima University, Hiroshima 734-8551, Japan.

Piotr Czauderna (P)

Department of Surgery for Children and Adolescents, Medical University of Gdansk, 80-210 Gdansk, Poland.

Milton Finegold (M)

Department of Pathology and Immunology, Baylor College of Medicine Houston, TX 77030, USA.

James H Feusner (JH)

Division of Hematology/Oncology, Children's Hospital & Research Center Oakland, Oakland, CA 94618, USA.

Marcio H Malogolowkin (MH)

Division of Pediatric Hematology Oncology, University of California-Davis, Davis, CA 95817, USA.

Rebecka L Meyers (RL)

Division of Pediatric Surgery, Primary Children's Hospital, Salt Lake City, UT 84113, USA.

Dolores Lopez-Terrada (D)

Department of Pathology and Immunology, Baylor College of Medicine Houston, TX 77030, USA.

Classifications MeSH